Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Hsu

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Molecular Cancer Therapeutics|July 4, 2012
Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging modelsXinhua Xie, Laisheng Li, Xiangsheng Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cellsHirohito Yamaguchi, Jennifer L Hsu, Chun-Te Chen, et al.
American Journal of Cancer Research|October 12, 2020
High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patientsChenhao Zhou, Jialei Weng, Chunxiao Liu, et al.
Biochemical and Biophysical Research Communications|November 3, 2010
Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasisXiaoyun Cheng, Weiya Xia, Jer-Yen Yang, et al.
American Journal of Cancer Research|August 11, 2018
Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killingLin-Lin Sun, Ri-Yao Yang, Chia-Wei Li, et al.
Cancer Cell|September 13, 2011
BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatmentJing-Yu Lang, Jennifer L Hsu, Funda Meric-Bernstam, et al.
Molecular Cancer Therapeutics|August 13, 2009
A novel hTERT promoter-driven E1A therapeutic for ovarian cancerXiaoming Xie, Jennifer L Hsu, Min-Gew Choi, et al.
Science Signaling|March 6, 2014
mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexesChao-Kai Chou, Heng-Huan Lee, Pei-Hsiang Tsou, et al.
Cancer Research|September 16, 2010
Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesisXiaoyun Cheng, Weiya Xia, Jer-Yen Yang, et al.
Journal for Immunotherapy of Cancer|October 4, 2023
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunityPaul Koller, Natalia Baran, Karine Harutyunyan, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Molecular Cancer Therapeutics|July 4, 2012
Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging modelsXinhua Xie, Laisheng Li, Xiangsheng Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cellsHirohito Yamaguchi, Jennifer L Hsu, Chun-Te Chen, et al.
American Journal of Cancer Research|October 12, 2020
High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patientsChenhao Zhou, Jialei Weng, Chunxiao Liu, et al.
Biochemical and Biophysical Research Communications|November 3, 2010
Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasisXiaoyun Cheng, Weiya Xia, Jer-Yen Yang, et al.
American Journal of Cancer Research|August 11, 2018
Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killingLin-Lin Sun, Ri-Yao Yang, Chia-Wei Li, et al.
Cancer Cell|September 13, 2011
BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatmentJing-Yu Lang, Jennifer L Hsu, Funda Meric-Bernstam, et al.
Molecular Cancer Therapeutics|August 13, 2009
A novel hTERT promoter-driven E1A therapeutic for ovarian cancerXiaoming Xie, Jennifer L Hsu, Min-Gew Choi, et al.
Science Signaling|March 6, 2014
mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexesChao-Kai Chou, Heng-Huan Lee, Pei-Hsiang Tsou, et al.
Cancer Research|September 16, 2010
Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesisXiaoyun Cheng, Weiya Xia, Jer-Yen Yang, et al.
Journal for Immunotherapy of Cancer|October 4, 2023
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunityPaul Koller, Natalia Baran, Karine Harutyunyan, et al.
Pageof 11